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Nutritional, immune, micronutrient and health  
status of HIV-infected children in care centres in Mangaung
Introduction
It has been estimated that there are 5.5 million people living with 
human immunodeficiency virus (HIV) infection in South Africa, 
250 000 to 300 000 of whom are children under the age of 
15 years.1 The prevalence of HIV infection is highest among 
women of reproductive age, that is 20 to 35 years, which places 
their offspring at particular risk of mother-to-child transmission.2 
In Africa, HIV infection has reversed gains in child survival and 
lowered life expectancy.3 In recent years in some provinces in 
South Africa, prevention of mother-to-child transmission (PMTCT) 
programmes have impacted on HIV infection prevalence in children 
by reducing HIV transmission.4
In HIV-infected children, acquired immunodeficiency syndrome (AIDS) 
is associated with an impaired nutritional status, growth failure and 
weight loss, as well as micronutrient deficiencies.5 All these factors 
may further contribute to the already compromised immune system 
and lead to poor prognostic outcome.
Approximately 25–30% of HIV-infected children in South Africa are 
underweight and 55–60% are stunted.6-8 Before the introduction 
of antiretroviral therapy into the Western Cape, only 7% of 193 
symptomatic HIV-infected children in Cape Town weighed above the 
third weight-for-age percentile.9 Multiple micronutrient deficiencies 
have also been found to affect more than 60% of South African 
HIV-infected children.6
A number of nongovernmental organisations in South Africa have 
been involved in the implementation of care centres for AIDS 
orphans. Such centres offer children access to care and support. 
Children are usually admitted on a semi-permanent basis. They 
usually visit family only during school holidays and/or weekends. 
At some centres, children receive day care, which includes breakfast, 
lunch as well as in-between snacks. No information is, however, 
available regarding the nutritional and micronutrient status of HIV-
infected children in these settings. 
The purpose of this study was to assess the nutritional, immune, 
micronutrient and health status of HIV-infected children in selected 
care centres in Mangaung. 
Abstract
Aim: To assess the nutritional, immune, micronutrient and health status of antiretroviral-naïve HIV-infected children.
Method: A cross-sectional descriptive study was undertaken between September 2004 and March 2006 amongst HIV-infected children of 
which none received antiretroviral therapy, in care centres in Mangaung, Free State.
Results: The study included 37 clinically stable and food-secure HIV-infected children. Their median age was 5.4 years (range 1.2–10.2 
years). Fifteen children (41%) were underweight, 30 (81%) were stunted and one (3%) was wasted. The most commonly observed clinical 
features were lymphadenopathy (84%), skin rashes (51%), hepatomegaly (32%) and pallor (41%). Eight per cent of children had features 
of TB, while 19% had a lower respiratory tract infection. The median viral load of the group (n = 35) was 117 000 copies/ml, the median 
CD4+ cell count was 477 cells/mm3 and the median CD4 percentage was 22.5%. A significant negative correlation could be demonstrated 
between viral load and nutritional indicators. Children had deficient serum levels relative to normal reference values for glutathione (91% 
of children), albumin (78%), vitamin A (63%), vitamin D (44%), zinc (38%) and vitamin E (13%). Sixty per cent of the children were anaemic 
and 30% were iron deficient.
Conclusion: A high prevalence of acute and chronic malnutrition and micronutrient deficiencies occurred among HIV-infected children 
residing in care centres. The study highlights the need to investigate early initiation of antiretroviral therapy and nutrition interventions, 
including aggressive supplementation, in order to improve the prognosis of these children. 
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Methods
Study design and sampling
One hundred and fifty-five food-secure, HIV-affected children in 
selected care centres in Mangaung were screened by enzyme-
linked immunosorbent assay (ELISA) to determine their HIV status. 
All centres in the area that provided care and support to AIDS 
orphans, with managerial support from and provision of health care 
by the Department of Health, were included. Most of the children 
in the centres were from an area within an urban township that 
includes formal and informal housing areas. All HIV-infected children 
in the care centres between August 2004 and March 2006 who had 
either been previously confirmed to be HIV infected (prior to the 
onset of the study) or had a positive ELISA screening result if older 
than 12 months were eligible for the study. Thirty-eight children 
were identified for the study, one of whom was excluded because of 
hospitalisation due to pneumonia. All these children were admitted 
to the care centres at least six weeks before the onset of the study. 
Thirty-seven children entered the cross-sectional descriptive study. 
Nutrition analysis of menus was done and actual portion sizes served 
over a three-day period were evaluated before study initiation by a 
registered dietitian. All the children were food secure and received 
two to three balanced meals per day, with in-between snacks, at 
the care centres. The diet and menus were set by a dietitian and 
the implementation was checked by the Quality Control Committee. 
The children received their required immunisations, were dewormed 
less than three months before the study and received regular vitamin 
A supplementation according to national immunisation guidelines. 
None of the children received antiretroviral treatment.
Nutritional status
Growth was assessed by determining weight-for-age, height-for-age 
and weight-for-height z-scores for all the children and comparing 
these measurements to the norms for physical growth of the National 
Centre for Health Statistics data.10 Anthropometric measurements 
were done by a trained dietitian using standardised techniques.11 
A SECA electronic scale (model 708) was used to determine the weight 
of the lightly clothed children to the nearest 0.1 kg. A stadiometer 
was used to measure the height of the children older than 24 months 
to the nearest 0.1 centimetre according to standardised techniques. 
In children younger than 24 months, the recumbent length was 
measured using a paediatric measuring board. 
Immunological, metabolic and micronutrient status
Following the nutritional and clinical assessment, fasting blood 
samples were collected. The CD4+ cell count, viral load, full blood 
count, as well as serum levels of cholesterol, albumin, glutathione, 
vitamin A, vitamin E, vitamin D, ferritin, zinc, folate and vitamin B12 
were measured. HIV status was classified according to the World 
Health Organization clinical staging (2006) and CD4+ counts and 
percentages were used to classify children into immunological 
categories according to the Centers for Disease Control (CDC) 
guidelines.12
The CD4+ lymphocyte cell count was determined on EDTA-anti-
coagulated whole blood samples using a flow cytometer. The plasma 
viral load (log10 HIV-1 RNA copies/ml) was quantified by means of 
a nucleic acid amplification test on a COBAS AMPLICOR (Roche 
Diagnostic System Inc). 
Plasma chemistry concentrations were quantified using serum 
prepared from whole blood clotted at room temperature. All the 
assays were performed by Pathcare, a local private laboratory, 
according to standardised techniques, and normal reference ranges 
were thus obtained from that particular laboratory. Serum albumin 
was measured by direct spectrophotometry, using a colorimetric 
assay (Beckman; catalogue no. 467858). The serum total cholesterol 
was measured by means of an enzymatic colorimetric assay 
(Beckman; catalogue no. 467825). Vitamin A (retinol) and vitamin 
E were quantified by high-performance liquid chromatography and 
vitamin D by radioactive binding protein assays. Ferritin (Bayer; 
catalogue no. 110746), vitamin B12 (Bayer; catalogue no. 110748) 
and folate (Bayer; catalogue no. 118551) were quantified by chem-
illuminescence assays and zinc (Randox Laboratories; catalogue 
no. ZN2341) by flame atomic absorption spectrometry. Blood 
micronutrient concentrations of the population group were compared 
with local age-related normal values. Myopathy (proximal weakness) 
was assessed by asking the children to stand from a sitting position 
with hands above their heads. Peripheral neuropathy was assessed 
by asking the children to walk on toes and heels and by evaluating 
handgrip and/or lower knee and ankle reflexes.
Health status
Health status was determined by means of a clinical examination 
undertaken by a trained medical doctor. The clinical examination 
included an assessment of the child’s vital signs, for example 
temperature, pulse rate and respiratory rate, and an examination of 
all the systems: general, respiratory, cardiovascular, abdominal and 
neurological. 
Ethical aspects
Written consent was obtained from the legal guardian of each child 
(either the nearest adult family member or if none available, the head 
of the institution who performed that duty). The study was approved 
by the Ethics Committee of the Faculty of Health Sciences of the 
University of the Free State, South Africa (ETOVS 190/00). 
Data entry and analysis
Frequencies and percentages were used to summarise the categorical 
data. The distribution of most numerical variables was skewed. 
It was therefore decided to use medians and quartiles to summarise 
these numerical variables. Nonparametric statistical methods (Mann-
Whitney and Kruskall-Wallis tests) were used to compare variables 
between subgroups. All analyses were done using SAS Version 9.1 
(2004). Epi Info Version 5 (1990) was used to calculate z-scores and 
percentiles of anthropometric data. Correlations between variables 
were determined with the Spearman rank correlation test. A p-value 
of less than 0.05 was considered to be significant. 
Results
General and nutritional status 
The 37 children’s median age was 5.4 years (range, from 1.2 to 
10.2 years); 16 (43%) were girls. The median (25th and 75th 
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quartiles) indicators of nutritional status were as follows: weight-for-
age z-score -1.97 (-2.48; -1.4), height-for-age z-score -2.59 (-3.35; 
-2.03) and weight-for-height z-score -0.66 (-0.85; 0.05). Stunting 
was commoner than underweight, with 81% (n = 30) of the children 
having a height-for-age z-score < -2, while 41% had a weight-for-
age z-score of < -2. 
Spearman rank correlation coefficients indicated significant but 
weak negative correlations between viral load and height-for-
age z-score (r = -0.42; p = 0.03) and weight-for-age z-score 
(r = -0.35; p = 0.04) respectively. No significant correlations could 
be demonstrated between growth indicators and CD4+ cell counts 
or percentage. A significant but weak positive correlation could be 
demonstrated between the weight-for-height z-score (r = 0.42; 
p = 0.03) and glutathione levels. A weak positive correlation 
approaching significance (r = 0.31; p = 0.06) was demonstrated 
between weight-for-age z-score and serum levels of glutathione 
as well. Apart from glutathione, no significant correlations could 
be demonstrated between serum levels of vitamin A, D, E and zinc 
and the z-scores for weight for age, height for age and weight for 
height.
Health status 
The most commonly occurring clinical features were lymphadenopathy 
(84%), HIV-related skin rashes (51%) and pallor (41%) (See 
Table I). Signs of lower respiratory tract infection were present 
in seven (19%) of the children. Three children (8%) were on TB 
treatment, with crepitations (43%) and hepatomegaly (32%) being 
the most common respiratory and abdominal pathology present 
respectively. Symptoms of diarrhoea were identified in six children 
(16%) during the clinical examination, while splenomegaly, vomiting 
and oral thrush occurred in less than 10% of the sample. Muscle 
weakness and peripheral neuropathy was present in 38% and 
35% respectively of the sample. No children had neck stiffness or 
encephalopathy. 
According to the WHO Clinical Staging of HIV for Infants and Children 
with Established HIV Infection, only four children could be classified 
as clinical stage 1, while seven were in stage 2, seven were in 
stage 3 and 19 were in stage 4. Although trends of decreased 
serum albumin and haemoglobin (Hb) levels amongst children in 
stages 3 and 4 could be observed, no significant correlations could 
be demonstrated between specific clinical features and nutritional, 
immune and biochemical indicators.
Immunological, metabolic and micronutrient status
The median (quartiles) viral load was 117 000 copies/ml (14 500; 
305 000) and the median (quartiles) CD4+ cell count 477 cells/mm3 
(300; 791). The median (quartiles) CD4+ percentage was 22.5% 
(14.2; 35.8). There was no significant correlation between the age 
of the children and the viral load (r = -0.12; p = 0.48). As expected, 
a significant (p = 0.04) but weak negative correlation (r = -0.35) 
was demonstrated between the total number of T-lymphocytes and 
the age of the children. According to the 1994 Revised Pediatric 
HIV Classification System,12 40% (14/35) of the group could be 
categorised as Category 1, with no evidence of immunosuppression; 
34.3% (12/35) were moderately immunosuppressed (Category 2) 
and 25.7% (9/35) were severely immunosuppressed (Category 3). 
According to the updated Southern African HIV Society guidelines for 
the management of HIV infection in children,13 32% (n = 12) of the 
children should have been treated with antiretroviral drugs, if these 
had been available to them at that stage.
The percentage of children with abnormal metabolic indicators, 
which for the purpose of this study included full blood count, serum 
albumin, serum cholesterol and certain micronutrient markers, is 
summarised in Table II. Median serum albumin levels were 32 g/l 
(28; 35), compared to the normal range of 37 to 52 g/l. Seventy-
eight per cent of the group presented with low serum albumin 
levels. Children in the severely immunosuppressed group had 
significantly (p = 0.02) lower serum albumin levels than children 
with no evidence of immunosuppression (See Table III). According 
to Spearman correlation coefficients, a significant but weak positive 
correlation was demonstrated between height-for-age z-score and 
serum albumin (r = 0.44).
Median serum ferritin and white blood cells were within the 
normal ranges for these variables, but median haemoglobin 
(10.8 g/dL) and haematocrit (0.33 l/l) concentrations were lower 
than the age-specific normal ranges. Of the total sample, 60% 
(n = 21) were anaemic (Hb < 11 g/dl for children below five years; Hb 
< 11.5 g/dl for children between five and 11 years) and 30% 
(n = 11) were iron depleted (serum ferritin less than 12 ng/mL).14 
Of the anaemic group 38% (n = 8) were iron depleted. Red blood cell 
morphology was not available to determine iron deficiency anaemia. 
No significant differences could be demonstrated between serum 
levels of haemoglobin, folate, vitamin B12 and ferritin in the various 
immune categories.
As summarised in Table II, low levels in relation to the normal 
reference range for micronutrients were found in 91.2% of children 
for glutathione, 62.5% for vitamin A, 43.8% for vitamin D, 38.2% 
for zinc and 12.5% for vitamin E. Sixty-nine per cent of the children 
suffered from two or more micronutrient deficiencies. Significant 
(p < 0.05) weak to moderate negative correlations were shown 
between viral load and the following micronutrient serum levels: 
vitamin A (r = -0.46), vitamin D (r = -0.39) and zinc (r = -0.36). 
Table I: Clinical features of HIV-infected children in care centres
Clinical sign n = 37 %
Lymphadenopathy 31 84
Skin rash (generalised dermatitis) 19 51
Pallor 15 41
Hepatomegaly 12 32
Ear infection 9 24
Clubbing 9 24
Oedema 8 21
Signs of lower respiratory tract infection 7 19
Mucosal lesions 6 16
Diarrhoea 6 16
Splenomegaly 3 8
Oral thrush 2 5
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Glutathione levels showed a nonsignificant weak 
negative (r = -0.33, p = 0.06) correlation with viral 
load. Assessing the micronutrient levels between the 
different groups (see Table III), classified according 
to the CDC CD4% classification, a significant 
difference could be demonstrated between the 
group with no evidence of suppression and the 
group with severe immunosuppression, in relation 
to levels of serum zinc (p < 0.01) and vitamin A 
(p = 0.05).
Children with low serum zinc levels had a 
significantly lower median CD4+ count (300 
vs 736 cells/mm3, p = 0.002). Although not 
significant, a similar tendency occurred for 
median viral load (250 500 [5.39 log] vs. 43 400 
[4.63 log], p = 0.06). Children with abnormally 
low vitamin A levels presented with significantly 
(p = 0.01) higher viral loads and lower CD4+ cell 
counts (p = 0.05). Both of these indicators could 
have been influenced by the acute phase response. 
Despite similar trends in relation to glutathione, 
vitamin D and vitamin E status, no significant 
differences could be demonstrated.
Table III: Median viral load, biochemical indicators and micronutrient levels according to CD4% – age-corrected CDC immunologic classification
Parameter Normal range Median values
Median in Category 1 No 
evidence of suppression 
(n; LQ; UQ)
Median in Category 2 
Moderately suppressed  
(n; LQ; UQ)
Median in Category 3 





Viral load copies/ml 117000
5 630  
(n = 14; 400; 43 400)
205 000  
(n = 11; 102 000; 480 000)
247 000 
(n = 9; 167 000; 294 000)
0.001
Albumin g/l 37–52 32
34  
(n = 14; 33; 43)
31  
(n = 12; 29; 33)
28  
(n = 9; 25; 32)
0.02
Cholesterol mmol/l 3–5 3
3.15  
(n = 14; 2.8; 3.9)
2.9  
(n = 12; 2.6; 3.2)
2.8  
(n = 9; 2; 2.8)
0.09
Haemoglobin g/dl 11.5–13.5 10.8
11.6  
(n = 14; 10.5; 12.5)
10.4  
(n = 12; 9.7; 11.6)
9.8  
(n = 9; 8.7; 11,.8)
0.21
Ferritin ng/ml 12–55 24
22.5  
(n = 14; 18; 29)
25  
(n = 12; 9; 41.5)
25  
(n = 9; 22; 55)
0.45
Folate nmol/ml > 12.19 36.2
44.6 ( 
n = 14; 36.1; 54.4)
29.2  
(n = 12; 25.1; 54.4)
33.1  
(n = 9; 29.7; 45.1)
0.22
Vitamin B12 pmol/ml 156–672 483
505  
(n = 14; 436; 581)
452  
(n = 12; 412; 636)
502  
(n = 9; 349; 674)
0.96
Vitamin A μg/dL 20–43 18.15
22.7  
(n = 13; 17.7; 24.8)
16.7  
(n = 11; 14.6; 20.8)
16.65  
(n = 8; 12.15; 18.65)
0.05
Vitamin D ng/ml 20–60 20
24  
(n = 13; 20; 26)
19  
(n = 11; 16; 21)
17  
(n = 8; 16; 22.5)
0.1
Vitamin E mg/dl 3–9 8.05
8.2  
(n = 13; 6.7; 9.6)
7.6  
(n = 11; 6.3; 10.3)
8.25  
(n = 8; 7; 9.05)
0.97
Zinc μmol/l 12–17 12
14.5  
(n = 14; 12; 15)
12  
(n = 12; 11; 12.5)
11  
(n = 8; 10.5; 11)
0.001
Glutathione mg/dl 24–37 18
19.5  
(n = 14; 17; 23)
17  
(n = 12; 11.5; 19.5)
17  
(n = 8; 13.5; 19.5)
0.12
Table II: Percentage of HIV-infected children with micronutrient concentrations and metabolic 
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*Laboratory error resulted in missing values of some of the variables
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Discussion
Paediatric HIV infection is associated with growth failure in 
most settings, even in children receiving antiretroviral drugs.6,15 
HIV-infected children in developing countries, and specifically South 
Africa,6,8 experience more severe growth retardation than observed 
in HIV-infected children in developed countries.13 Data from an earlier 
study16 amongst preschool children from informal settlements in 
Mangaung showed figures for underweight and stunting of below 
20% and 30% respectively. In this study, figures for HIV-infected 
children in the same area were 41% for underweight and 81% 
for stunting, indicating that HIV infection further compromises 
the nutritional status of this socio-economically deprived group 
of children. Even access to regular, balanced meals in the care 
centres (managed by a quality control committee) could not improve 
the nutritional status of these AIDS orphans in the absence of 
antiretroviral drugs. Without any available data on quality control of 
diets and the implementation thereof in similar centres in other parts 
of the country, it is not possible to determine unique risk factors in 
this group of HIV-infected children. It can, however, be assumed that 
AIDS orphans, especially during the period before acceptance into a 
care centre, have less access to health care, while basic needs, for 
example for sufficient nutrition, may have been denied as well. 
A higher HIV-1 viral load has been associated with a greater risk of 
growth failure as well as poor linear growth in children.17-19 In this 
study, a similar trend could be observed with significant correlations 
between viral load and nutritional indicators. However, no significant 
correlations could be demonstrated between nutritional indicators 
and median CD4+ cell counts. Several factors may contribute to 
growth failure in HIV-infected children. In more than one study,19,20 
growth failure has been linked to a decreased resting energy 
expenditure (REE) and total energy expenditure (TEE), most likely 
as a result of deficient energy intake and a lower fat-free mass. 
As HIV-infected infants with growth failure have as much as a five-
fold increase in the risk of early death,21,22 efforts to reverse growth 
failure in children attending care centres should receive priority, 
preferably by providing antiretroviral drugs and aggressive nutrition 
support with energy-dense nutrition supplements to supplement the 
meals these children currently receive. 
Apart from wasting, HIV infection also causes micronutrient 
deficiencies, which can further compromise the immune system, 
resulting in a poorer outcome.23 Especially in Africa, deficiencies of a 
number of these micronutrients are more prevalent among children 
infected with HIV than among HIV-negative children.24 This study 
confirmed that micronutrient deficiencies frequently occurred in 
the majority of children, with the highest prevalence of deficiencies 
relating to glutathione, vitamin A, zinc and vitamin D, which are 
all essential in maintaining the immune function. However, only 
glutathione levels correlated with growth indicators. Our results 
seem to be in accordance with a study by Arpadi25 that found that the 
plasma glutathione levels in HIV-infected children were decreased 
by 24% if compared to HIV-negative controls. HIV-infected children 
with growth failure had glutathione levels that were further reduced 
by 35%. 
These results should, however, be treated with caution, as they are 
affected by the acute-phase response and thus are susceptible 
to changes in binding proteins.26 Serum zinc and vitamin A levels 
normally decrease during the acute phase response, while serum 
levels of ferritin increase. A small number (14%) of children had 
increased ferritin levels and as C-reactive protein levels were not 
available, serum levels of micronutrients in some children may not 
accurately reflect true micronutrient levels. This is supported by the 
fact that the children with increased ferritin levels had significant 
decreases in both CD4+ cell counts and serum zinc levels. 
Previous studies amongst HIV-infected children in South Africa 
indicated a significant relationship between immunological status 
and Hb levels.6 In this study, children with higher viral loads had 
significantly lower Hb levels as well. A similar trend could be observed 
between CD4% and Hb levels whereby the median Hb value in the 
Category 3 group (9.8 g/dl) was lower than in the Category 1 group 
(11.6 g/dl). There was no correlation between the prevalence of iron 
depletion and immune suppression in this particular sample. 
Decreased serum levels of albumin and cholesterol significantly 
correlated with higher viral loads, lower CD4%, lower CD4:CD8, as 
well as stunting. Unlike HIV-infected children in developed countries 
in whom abnormal protein levels could not be demonstrated,27 the 
majority of children in this study not only had abnormally low values 
but these correlated with a compromised immune system as well. 
Stunted HIV-infected children in care centres are therefore more 
likely to have anaemia and decreased serum levels of albumin and 
cholesterol. 
Children with abnormally low vitamin A and zinc levels had 
significantly higher viral loads and lower CD4+ cell counts. Though no 
significant differences could be demonstrated in relation to vitamins 
D and E, a trend could be observed whereby children with abnormal 
low levels of these antioxidants had higher viral loads and lower CD4+ 
cell counts. If indeed these deficiencies are related to immune status 
rather than growth, it remains to be seen whether these deficiencies 
can be reversed by nutritional supplementation and whether that 
can impact on the immune status as well. Unfortunately, other than 
vitamin A and zinc, no randomised trials have examined the impact 
of micronutrient supplementation in children born to HIV-infected 
mothers. In developing countries, vitamin A supplementation showed 
reductions in child morbidity and mortality, also in HIV-infected 
children.28,29
The limited sample size and the lack of a control group in terms 
of HIV-negative children were the biggest limitations of the study. 
All care centres initially earmarked for the study indicated that 
their main focus was the care and support of HIV-infected children. 
However, of the more than 150 children in six centres, only 38 had 
a positive ELISA. It is therefore evident that the majority of children 
who are currently receiving care and support from institutions in 
this part of the country are affected by HIV/AIDS and not infected 
as assumed before the commencement of the study. It may be very 
valuable to determine the nutritional and health status of these HIV-
affected children to ensure timely intervention if needed.
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The correlation demonstrated in this study between viral loads and 
stunting is in accordance with international data that have shown 
that compromised statural growth is superior to weight-based 
criteria as an indicator of disease progression.30,31 In the absence 
of viral loads being performed routinely in HIV-infected children 
living in care centres in South Africa, the severity of stunting may 
be a more easily accessible indicator of disease progression. 
Although the deprived socio-economic background these children 
originate from cannot be ignored as contributing factor to the 
underlying malnutrition observed, the nutritional problems regarding 
underweight and stunting as well as the widespread micronutrient 
deficiencies emphasise the need for early initiation of antiretroviral 
therapy, especially in the case of children qualifying for it. The 
impact of aggressive macro- and micronutrient supplementation in 
addition to the high-quality food they currently receive should also 
be investigated to determine whether rehabilitation of growth and 
micronutrient deficiencies is possible at all in HIV-infected children 
in these relatively controlled settings. This may have critical long-
term implications for these children with respect to their future 
development, school achievement and economic productivity.
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